Beijing Friendship Hospital Metabolic Surgery Database
Status
Conditions
Details and patient eligibility
About
Metabolic surgery, as a recognition treatment option for patients with clinical morbid obesity, is gaining increasing appreciation. In addition to substantial weight loss, emerging studies have highlighted that metabolic surgery can substantially ameliorate obesity-related metabolic diseases, including but not limited to type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea-hypopnea syndrome (OSAHS) and polycystic ovary syndrome (PCOS)in severely obese patients. However, further investigations with larger sample size and longer observation time still needed to clarity the efficacy and safety of metabolic surgery in Chinese patients with obesity and encouraging future research in this field.
Enrollment
Sex
Volunteers
Inclusion criteria
- be able to receive metabolic surgery (LSG or LRYGB)
Exclusion criteria
- can not be able to understand and willing to participate in this registry with signature
Trial contacts and locations
Loading...
Central trial contact
Mengyi Li, M.D.; Zhongtao Zhang, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal